GSK3B and cancer: Several other studies have also shown that c-Met expression enhances the Wnt/β-catenin signaling and impedes GSK3β from phosphorylating β-catenin in CRC; this subsequently promotes β-catenin translocation into the nucleus leading to cancer initiation [27,28].